Dublin, March 03, 2017 -- Research and Markets has announced the addition of the "Incontinence and Ostomy Care Global Market - Forecast To 2023" report to their offering.
The incontinence and ostomy care global market is expected to grow at mid-single digit CAGR to reach $22,150.3 million by 2023.
Factors driving the incontinence and ostomy care market include, increase in aging population, increase in awareness & use of personalized products are all contributing to the growth of incontinence and ostomy care global market. Alternative medical treatments, the presence of local manufacturers and low reimbursement are hampering the market growth. Advancement of technology with its wide application areas shows that incontinence and ostomy care market has vast opportunities in the coming years.
The steep rise in aging population, advancement in technology, awareness of people about treatment options and favorable government policies are driving factors of incontinence and ostomy care products market. However, Asian countries especially India and China are the fastest growing regions with its growing demand for incontinence and ostomy care products.
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increase in Aging Population
3.3.1.2 Development of Innovative and Personalized Products
3.3.1.3 Increase in Awareness and Acceptance
3.3.1.4 Increase in Prevalence of Diseases
3.3.2 Restrains and Threats
3.3.2.1 Environment and Disposal Concerns
3.3.2.2 Alternative Medical Treatment
3.3.2.3 Limited Reimbursement
3.4 Regulatory Affairs
3.4.1 U.S.
3.4.2 Europe
3.4.3 China
3.4.4 Japan
3.4.5 Australia
3.5 Reimbursement Scenario
3.5.1 CPT Codes
3.6 Patent Analysis
3.7 Technology Advancements
3.7.1 Biomaterial Advancements
3.7.2 Increased Absorbence
3.7.3 Moldable Technology
3.7.4 Next Generation Ostomy Implants
3.8 Upcoming Technology and Product Launch
3.9 Clinical Trial Data
3.10 Porter's Five Force Analysis
3.10.1 Threat of New Entrants
3.10.2 Threat of Substitutes
3.10.3 Bargaining Power of Suppliers
3.10.4 Bargaining Power of Buyers
3.10.5 Rivalry Among Existing Competitors
3.11 Supply Chain Analysis
3.12 Market Share Analysis by Major Players
4 Incontinence and Ostomy Care Global Market, by Products
4.1 Introduction
4.2 Incontinence and Ostomy Care Products
4.2.1 Incontinence Care Products
4.2.1.1 Disposable
4.2.1.1.1 Absorbent
4.2.1.1.2 Incontinence Bags
4.2.1.1.3 Deodorizer
4.2.1.1.4 Clamps and Cleaners
4.2.1.1.5 Urinals
4.2.1.1.6 Anal Irrigation System
4.2.1.1.7 Incontinence Catheter
4.2.1.1.8 Pessaries
4.2.1.1.9 Others
4.2.1.2 Implants
4.2.1.2.1 Sacral Nerve Stimulation (SNS)
4.2.1.2.2 Tibial Nerve Stimulation (TNS)
4.2.1.2.3 Sphincters
4.2.1.2.4 Slings
4.2.2 Ostomy Care Products
4.2.2.1 Ostomy Bags
4.2.2.1.1 One-Piece Ostomy Bags
4.2.2.1.2 Two-Piece Ostomy Bags
4.2.2.2 Skin Barriers
4.2.2.3 Deodorants
4.2.2.4 Irrigation Products
4.2.2.5 Other Products
4.3 Incontinence and Ostomy Care Products, by Utility
4.3.1 Introduction
4.3.2 Security and Leakage Control
4.3.3 Protection and Cleansing
4.3.4 Odor Control
4.3.5 Irrigation Products
5 Incontinence and Ostomy Care Global Market, by Applications
5.1 Introduction
5.2 Women Health Related
5.3 GI Tract Diseases
5.4 Oncology
5.5 Neurological Conditions
5.6 Urinogenital Diseases
5.7 Others
6 Incontinence and Ostomy Care Global Market, by End-Users
6.1 Introduction
6.2 Hospitals
6.3 Home Care
6.4 Private Clinics
7 Regional Analysis
8 Competitive Landscape
8.1 Introduction
8.2 Others
8.3 New Product Launches
8.4 Agreements, Acquisitions & Collaboration
9 Major Companies
9.1 B. Braun Melsungen AG
9.2 Coloplast
9.3 Convatec Healthcare B S.A.R.L
9.4 Hollister Incorporated
9.5 Kimberly-Clark Corporation
9.6 Medtronic, Plc
9.7 Ontex
9.8 Paul Hartmann AG
9.9 the Procter & Gamble Company
9.10 Salts Healthcare
9.11 Svenska Cellulosa Aktiebolaget SCA
Companies Mentioned
- 3M
- A.M.I. GmbH
- Abena
- Abiss
- Absorbent Products Company Inc.
- Adapta Medical Inc.
- Advantage Urinal Systems
- Alcare
- Asaleo
- Axonics Modulation Technologies, Inc
- B. Braun Melsungen AG
- Beaucare Medical Ltd.
- Betatech Medical
- Birchwood Laboratories
- Bluewind Medical
- Boston Scientific
- Bray Group Ltd.
- C. R. Bard
- Caldera Medical Inc.
- Capatex Ltd.
- Changzhou Medical Appliances General Factory Co., Ltd
- Chiaus
- CL Medical
- Cogentix Medical
- Coloplast AG
- Convatec Inc.
- Cook Medical, Inc.
- Cousin Biotech
- Covalon Technologies
- Cymed Ostomy Co.
- Dansac
- Dermarite Industries
- Dipromed
- Domtar
- Eakin
- Eurofil S.R.L.
- Everyway Medical Instruments Co., Ltd
- Fater S.P.A.
- Finesse Medical Ltd.
- First Quality Enterprises, Inc.
- Flat-D Innovations Inc.
- Flexicare Medical
- For Life
- Fuburg
- Geberit
- Genairex
- GT Urological LLC
- Helioscopie
- Hengan Group
- Hollister Inc.
- Hunter Urology
- Hypermarcas SA
- Incontrol Medical, LLC
- Invacare Corporation
- Johnson & Johnson (Ethicon)
- Kimberly-Clark Corporation
- Koyo Corp
- Lantiseptic
- Lew Jan Textile
- Marlen
- Marlen Healthcare
- Medgyn
- Medtronic, Inc.
- Mega Disposables S.A.
- Myopowers Medical Technologies
- Na'scent
- Nilodor Clean Earth
- Nobel Hygiene
- Nu-Hope Labs
- Nuvectra
- Oakmed Ltd.
- Ontex
- Ostofresh
- Ostomy Essentials
- Ostomy Supersan
- Ostomycure
- Ostosolutions
- Oxmed International
- Panpac Medical Corporation
- Paul Hartmann
- Peak Medical Ltd.
- Pelican Healthcare
- Perfect Choice Medical Technologies
- PFM Medical AG
- Portia Pessaries
- Prevail
- Procter & Gamble (P&G)
- Reinhard Becker Medical
- Renew Medical
- Resilia Medical Solutions
- Safe N Simple LLC
- Salts Healthcare
- Santex
- Sealed Air
- Securi-T
- Smith & Nephew
- Sterimed Medical Devices Pvt. Ltd.
- Stomalife
- Svenska Cellulosa Aktiebolaget
- THT Bio-Science
- Torax Medical Inc.
- Torbot Group Inc.
- Tranquillity
- Trio Healthcare Ltd.
- Tytex A/S
- Unicharm Corporation
- Unique Wellness
- Urocare Products
- Welland Medical
- Wuhan Dahua Weiye Pharmaceutical Chemical Co., Ltd.
- Zephyr Surgical Implant
For more information about this report visit http://www.researchandmarkets.com/research/h8hlps/incontinence_and
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Personal Care Products , Medical Devices


Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos
How Technology Is Reshaping Modern Business: From Operations to Customer Experience
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks
Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
NVIDIA Acquisition Rumors Dismissed by Morgan Stanley as Strategically Flawed
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 



